Financials
- Market Capitalization 583.63 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2664 | CSTL Castle Biosciences, Inc. - Common stock | 24.23 USD | +0.87% | -1.30% | +18.83% | -1.56% | 734.89 M USD | ||
| 2810 | MYGN Myriad Genetics, Inc. - Common Stock | 6.19 USD | -1.90% | +1.14% | +40.68% | -25.15% | 584.63 M USD | ||
| 3230 | LAB Standard BioTools Inc. - Common Stock | 0.86 USD | +2.38% | -8.51% | +3.61% | -31.20% | 335.46 M USD | ||
| 3282 | PRE Prenetics Global Limited - Class A Ordinary Share | 18.91 USD | -3.42% | +6.48% | -5.17% | +131.74% | 319.09 M USD |
Frequently asked questions about Fulgent Genetics, Inc. - Common Stock
What is the Fulgent Genetics, Inc. - Common Stock stock price today?
The current price of Fulgent Genetics, Inc. - Common Stock (FLGT) is 20.55. Over the past 24 hours, the stock has changed by -2.19%. Follow the FLGT chart for real-time price dynamics.
What is the stock ticker of Fulgent Genetics, Inc. - Common Stock?
Fulgent Genetics, Inc. - Common Stock trades under the ticker FLGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fulgent Genetics, Inc. - Common Stock stock going up?
FLGT has changed by -2.00% over the last week, +14.55% over the last month, and -13.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Fulgent Genetics, Inc. - Common Stock net income for the last quarter?
Fulgent Genetics, Inc. - Common Stock reported net income of -24.83 M for the last quarter. The previous quarter showed -23.42 M, which means net income changed by -6.01%.
How many employees does Fulgent Genetics, Inc. - Common Stock have?
As of the latest available data, Fulgent Genetics, Inc. - Common Stock has 1 315 employees. Workforce size can provide additional context about the company's scale and operations.
What is Fulgent Genetics, Inc. - Common Stock EBITDA?
Fulgent Genetics, Inc. - Common Stock EBITDA is -28.62 M, and its EBITDA margin is -40.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Fulgent Genetics, Inc. - Common Stock stock?
You can buy Fulgent Genetics, Inc. - Common Stock (FLGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fulgent Genetics, Inc. - Common Stock stock?
Investing in Fulgent Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FLGT chart and related analysis on metatrader.com as part of your research.